Castellum Inc (AMEX:CTM) does about 1.78M shares in volume on a normal day but saw 1229933 shares change hands in the recent trading day. The company now has a market cap of 97.17M USD. Its current market price is $1.07, marking no change compared to the previous close of $1.07. The 52 week high reached by this stock is $2.83 whilst the lowest price level in 52 weeks is $0.12. The script in recent trading has seen the stock touch a high of $3 and a low of $3.
The consensus objective for the share price is $3.00, suggesting that the stock has a potential upside of 64.33% over the period. The median price target is 64.33% away from the current levels at $3.
The current price level is -4.40%, 3.37%, and 45.83% away from its SMA20, SMA50, and SMA200 respectively, with the CTM price moving below the 50-day SMA on current market day. Castellum Inc (CTM) stock is down -9.32% over the week and 7.00% over the past month. Its price is 502.82% year-to-date and -46.50% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year. Expected sales for next quarter are $14.63M, which analysts say will come at $54.5M for the current fiscal year and next year at $56.55M. In addition, estimates put the company’s current quarterly revenue at an average of $13.45M.
Its 12-month price target is $3. To reach the target analysts have set, the stock logically needs to grow 64.33 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $3, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $3.
Outstanding shares total 86.04M with insiders holding 25.42% of the shares and institutional holders owning 3.66% of the company’s common stock. The company has a return on investment of -21.45% and return on equity of -36.17%. The forward price to earnings ratio is 107.00. The beta has a value of -4.04. Price to book ratio is 3.53 and price to sales ratio is 2.16.
